Friday, May 1, 2026

SK Chemicals’ Joins Tablet Surpasses 700 Billion KRW in Sales… What’s Behind the Osteoarthritis Drug’s Success?

SK Chemicals' Joins Tablets, a natural osteoarthritis treatment, surpasses 700 billion KRW in sales, marking a significant milestone in Korea.

Inside the North Korean Remittance Case: Key Allegations Against Prosecutor Park and Political Fallout Explained

The investigation into the North Korea remittance case intensifies, with Prosecutor Park named a suspect amid allegations of witness coercion.

‘SORRY! WE FAILED! BUT WE TRIED!’: Lee Government’s Only Achievement Is Its 6-Month Marathon Of Excuses

The Lee Jae Myung administration highlights key achievements in diplomacy and security at its six-month briefing, aiming for inter-Korean peace.

Tag: Johnson & Johnson

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us